| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 10, 1066-1076, Copyright © 1996 by Endocrine Society
ARTICLES |
AS Jobert, I Fernandes, G Turner, C Coureau, D Prie, RA Nissenson, G Friedlander and C Silve
INSERM U 426, Faculte de Medecine Xavier Bichat, Paris, France.
Using a PCR-based strategy, two variants of the PTH/PTH-related peptide (PTH-rp) receptor mRNA were identified in human kidney, SaOS-2 human osteoblast cells, and rat bone that are produced by alternative splicing of exons coding for the N-terminal portion of the receptor. In the S-N3-E2 isoform, the exon coding the signal peptide (S) is spliced to an alternative 3'-acceptor site, producing a product respecting the reading frame, but in which the E1 exon is replaced by 12 amino acids derived from the N3 intron. In the S-E2 isoform, in which the E1 exon is deleted by cassette exclusion, the reading frame is changed, but a truncated receptor may be produced by reinitiation of translation at an overlapping stop/start codon. After transfection of COS and Chinese hamster ovary cells with the originally described S-E1-E2 isoform and the two splice variants, active transcription of PTH/PTH-rp receptor mRNA was detected by RT-PCR in all cases. Cell lines transfected with the S-E1-E2 and S-N3-E2 isoforms displayed a 15- to 25-fold and 2- to 3- fold increase, respectively, in cAMP content after stimulation with 2.4 x 10(-7) M human PTH(1-34), whereas cells transfected with the S-E2 isoform did not respond. PTH elicited an increase in intracellular calcium only in cells transfected with the S-E1-E2 isoform. Studies evaluating the surface expression of receptors using anti-human PTH/PTH- rp receptor antibodies and the ability of transfected cells to bind [125I]PTH-rp indicated that the low or absent responses to PTH stimulation resulted, at least in part, from low surface expression of the S-N3-E2 and S-E2 isoforms. These studies support the conclusion that exon E1 is extremely important in promoting surface expression of the PTH/PTH-rp receptor but indicate that isoforms lacking this exon can retain the ability to recognize PTH. The possible intracellular expression of these splice variants, which account for 15-20% of total PTH/PTH-rp receptor mRNA, needs to be evaluated.
This article has been cited by other articles:
![]() |
A. Couvineau, V. Wouters, G. Bertrand, C. Rouyer, B. Gerard, L. M. Boon, B. Grandchamp, M. Vikkula, and C. Silve PTHR1 mutations associated with Ollier disease result in receptor loss of function Hum. Mol. Genet., September 15, 2008; 17(18): 2766 - 2775. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-Q. Liu, S. Tan, M. C. Mendel, R. J. Murrills, B. M. Bhat, B. Schlag, R. Samuel, J. J. Matteo, R. de la Rosa, K. Howes, et al. Isogenic Human Cell Lines for Drug Discovery: Regulation of Target Gene Expression by Engineered Zinc-Finger Protein Transcription Factors J Biomol Screen, June 1, 2005; 10(4): 304 - 313. [Abstract] [PDF] |
||||
![]() |
S. Ledoux, D. Laouari, M. Essig, I. Runembert, G. Trugnan, J.B. Michel, and G. Friedlander Lovastatin Enhances Ecto-5'-Nucleotidase Activity and Cell Surface Expression in Endothelial Cells: Implication of Rho-Family GTPases Circ. Res., March 8, 2002; 90(4): 420 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Wysolmerski, S. Cormier, W. M. Philbrick, P. Dann, J.-P. Zhang, J. Roume, A.-L. Delezoide, and C. Silve Absence of Functional Type 1 Parathyroid Hormone (PTH)/PTH-Related Protein Receptors in Humans Is Associated with Abnormal Breast Development and Tooth Impaction J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1788 - 1794. [Abstract] [Full Text] |
||||
![]() |
P. Esbrit and J. Egido The emerging role of parathyroid hormone-related protein as a renal regulating factor Nephrol. Dial. Transplant., August 1, 2000; 15(8): 1109 - 1111. [Full Text] [PDF] |
||||
![]() |
W. Chang, C. Tu, T.-H. Chen, L. Komuves, Y. Oda, S. A. Pratt, S. Miller, and D. Shoback Expression and Signal Transduction of Calcium-Sensing Receptors in Cartilage and Bone Endocrinology, December 1, 1999; 140(12): 5883 - 5893. [Abstract] [Full Text] |
||||
![]() |
D. A. Rubin and H. Juppner Zebrafish Express the Common Parathyroid Hormone/Parathyroid Hormone-related Peptide Receptor (PTH1R) and a Novel Receptor (PTH3R) That Is Preferentially Activated by Mammalian and Fugufish Parathyroid Hormone-related Peptide J. Biol. Chem., October 1, 1999; 274(40): 28185 - 28190. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Rubin, P. Hellman, L. I. Zon, C. J. Lobb, C. Bergwitz, and H. Juppner A G Protein-coupled Receptor from Zebrafish Is Activated by Human Parathyroid Hormone and Not by Human or Teleost Parathyroid Hormone-related Peptide. IMPLICATIONS FOR THE EVOLUTIONARY CONSERVATION OF CALCIUM-REGULATING PEPTIDE HORMONES J. Biol. Chem., August 13, 1999; 274(33): 23035 - 23042. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Friedman, F. A. Gesek, P. Morley, J. F. Whitfield, and G. E. Willick Cell-Specific Signaling and Structure-Activity Relations of Parathyroid Hormone Analogs in Mouse Kidney Cells Endocrinology, January 1, 1999; 140(1): 301 - 309. [Abstract] [Full Text] |
||||
![]() |
A.-S. Jobert, C. Leroy, D. Butlen, and C. Silve Parathyroid Hormone-Induced Calcium Release from Intracellular Stores in a Human Kidney Cell Line in the Absence of Stimulation of Cyclic Adenosine 3',5'-Monophosphate Production Endocrinology, December 1, 1997; 138(12): 5282 - 5292. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Schipani, G. S. Jensen, J. Pincus, R. A. Nissenson, T. J. Gardella, and H. Jüppner Constitutive Activation of the Cyclic Adenosine 3',5'-Monophosphate Signaling Pathway by Parathyroid Hormone (PTH)/PTH-Related Peptide Receptors Mutated at the Two Loci for Jansen's Metaphyseal Chondrodysplasia Mol. Endocrinol., June 1, 1997; 11(7): 851 - 858. [Abstract] [Full Text] |
||||
![]() |
S. Ledoux, D. Laouari, M. Essig, I. Runembert, G. Trugnan, J.B. Michel, and G. Friedlander Lovastatin Enhances Ecto-5'-Nucleotidase Activity and Cell Surface Expression in Endothelial Cells: Implication of Rho-Family GTPases Circ. Res., March 8, 2002; 90(4): 420 - 427. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |